Evidence map›Paper›PMID 31205559›Full record

ArticleJournal of Cancer2019

ERG Tumor Type is Less Frequent in High Grade and High Stage Prostate Cancers of Chinese Men.

Jiang Baohong, Jason Sedarsky, Shiv Srivastava, Isabell Sesterhenn, Albert Dobi, Li Quanlin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jiang BaohongDepartment of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Jason SedarskyDepartment of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Shiv SrivastavaDepartment of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Isabell SesterhennThe Joint Pathology Center, Silver Spring, Maryland USA.
Albert DobiDepartment of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Li QuanlinDepartment of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Uniformed Services University of the Health Sciences · USDalian Medical University · CNFirst Affiliated Hospital of Dalian Medical University · CNWalter Reed National Military Medical Center · US

Funding

Cell Specific Expression Signatures in Prostate Cancer (RO1 DK065977)R01CA162383 · NCI · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SRIVASTAVA, SHIV · 2011 to 2015
$1.1M
Cell Specific Expression Signatures in Prostate CancerR01DK065977 · NIDDK · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SRIVASTAVA, SHIV · 2004 to 2007
$688k
NCI NIH HHS R01 CA162383NIDDK NIH HHS R01 DK065977
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChineseERGhigh-grade tumorsoncogeneprostate cancer

Identifiers

PMID31205559
PMCPMC6548164
OpenAlexW2946833615

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.